Table 3.
Appropriateness of empiric therapy
| Ceftolozane/tazobactam | Piperacillin/tazobactam | |
|---|---|---|
| Resistant to initial therapy (%) | 7.8 | 20.2 |
| Susceptible to initial therapy (%) | 92.2 | 79.8 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.